StockMirror — Stock Screener

NH Q2 FY27 Results & Earnings Analysis

Sentiment: Good (Confidence: high)

Earnings Summary

Narayana Hrudayalaya reported a strong performance for Q2 FY27, driven by its India business which saw 9% QoQ revenue growth and margin expansion from operating leverage. The company's strategy is focused on volume growth by providing affordable, high-quality care, rather than targeting margins, which management believes are already best-in-class. The international business showed mixed results: Cayman continues to perform exceptionally well with a sharp reduction in insurance losses, while the newly acquired UK business faces revenue headwinds but is on track with cost synergies. Management is focused on long-term growth by building an integrated multi-geography healthcare system, and expects its investments, including the insurance business, to contribute to a non-volatile, profitable future.

Management Tone

Revenue Growth Drivers

Growth vs Margin Focus

Management explicitly stated that they do not target specific margins. Their mission is to cater to a large pool of patients with affordable pricing, and margin is seen as a consequence of efficiency, not the primary goal. The clear focus is on pursuing volume growth to access the largest patient po

About Narayana Hrudayalaya Limited

Narayana Hrudayalaya Limited (NH) is listed on NSE. View the latest earnings analysis, AI-powered insights, and sentiment data on StockMirror.

Explore More